| Janus Electric Holdings Limited (JNS) ORDINARY FULLY PAID |
Utilities |
$17 |
Janus Electric Announces Canadian Strategic Partnership
|
29 Jan 2026 10:16AM |
$0.125 |
$0.135 |
risen by
8%
|
|
JNS - Price-sensitive ASX Announcement
Full Release
Key Points
- Janus Electric partners with Canadian consortium for circular energy projects.
- Agreement involves exporting conversion kits from Australia to Canada.
- Batteries to be manufactured locally in Canada by partner Electrovaya.
- The project aims to create a 'Closed-Loop Logistics Hub' powered by renewable energy.
- Partnership addresses long-haul electrification challenges using battery-swapping technology.
- Project funding and final terms are pending governmental incentives and approvals.
- Expected deployment includes conversion kits, batteries, and charge stations starting in 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Trek Metals Limited (TKM) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$113 |
Notification of cessation of securities - TKM
|
29 Jan 2026 10:12AM |
$0.115 |
$0.155 |
risen by
34.78%
|
|
| Wellnex Life Limited (WNX) ORDINARY FULLY PAID |
Consumer Staple |
$3 |
Appendix 4C and Quarterly Report for Dec 2025 Quarter
|
29 Jan 2026 10:12AM |
$0.150 |
$0.045 |
fallen by
70%
|
|
WNX - Price-sensitive ASX Announcement
Full Release
Key Points
- Operating cash outflow reduced to $0.16 million.
- Revenue increased by 31.5% due to improved trading conditions.
- Customer cash receipts reached $5.10 million.
- Gross profit rose to $2.1 million, a 16.7% increase.
- Brand sales declined to $3.8 million due to strategic asset consolidation.
- Total financing facilities available were approximately $11.65 million.
- Payments to related parties amounted to $0.36 million for directors and executives.
- Focus remains on turnaround strategy and improving cash conversion.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Aeris Resources Limited (AIS) ORDINARY FULLY PAID |
Materials |
$446 |
QUARTERLY RESULTS PRESENTATION
|
29 Jan 2026 10:12AM |
$0.700 |
$0.373 |
fallen by
46.79%
|
|
AIS - Price-sensitive ASX Announcement
Full Release
Key Points
- Aeris Resources reported strong operating performance with a solid closing cash position of $106.4 million.
- Copper equivalent production for the group was 10.1kt, with costs well managed across the group.
- Tritton's production was 5.0kt Cu at an AISC of A$3.94/lb, aligning with the planned focus on waste stripping at Murrawombie Pit.
- Cracow's Q2 FY26 gold production was 11.1koz, ahead of plan, with an AISC of A$3,278/oz.
- Drilling commenced at the Golden Plateau open pit target at Cracow, and high-grade intersections were reported at Tritton's Avoca Tank and Budgerygar.
- Aeris completed a successful $80 million placement and a $21.6 million oversubscribed SPP, leading to the repayment of a $40 million WHSP facility, rendering the company debt-free.
- The divestment of North Queensland is expected to be completed next quarter.
- Stage 2 waste stripping is underway at Murrawombie Pit, with ore delivery to the mill expected next quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Alpha HPA Limited (A4N) ORDINARY FULLY PAID |
Materials |
$1,064 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 Jan 2026 10:11AM |
$0.845 |
$0.733 |
fallen by
13.31%
|
|
A4N - Price-sensitive ASX Announcement
Full Release
Key Points
- Continuous production at the HPA First Project Stage 1.
- Strong demand for alumina products from the semiconductor sector.
- Corporate funding of $30 million from QIC Critical Minerals and Battery Technology Fund.
- Advancement in Stage 2 HPA First Project for increased production capacity.
- Net cash outflow from operations but positive financing activities.
- Negotiating supply contracts in Japan and South Korea.
- Robust product demand in semiconductor and pharmaceutical sectors.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ramelius Resources Limited (RMS) ORDINARY FULLY PAID |
Materials |
$5,718 |
Conference call registration details
|
29 Jan 2026 10:10AM |
$5.060 |
$3.015 |
fallen by
40.42%
|
|
| Alpha HPA Limited (A4N) ORDINARY FULLY PAID |
Materials |
$1,064 |
Proposed issue of securities - A4N
|
29 Jan 2026 10:09AM |
$0.845 |
$0.733 |
fallen by
13.31%
|
|
| H3 Energy Limited (H3E) ORDINARY FULLY PAID |
Energy |
$9 |
Becoming a substantial holder
|
29 Jan 2026 10:09AM |
$0.010 |
$0.008 |
fallen by
20%
|
|
| Mesoblast Limited (MSB) ORDINARY FULLY PAID |
Health Care |
$2,893 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 Jan 2026 10:05AM |
$2.680 |
$2.235 |
fallen by
16.60%
|
|
MSB - Price-sensitive ASX Announcement
Full Release
Key Points
- Ryoncil® net revenues increased to US$30 million.
- Entered a US$125 million credit facility at 8% interest.
- Cash balance at December 31, 2025, was US$130 million.
- Net operating cash outflow for the quarter was US$16 million.
- Anticipated reduction in net cash spend over future periods.
- Ryoncil® pivotal trial for label extension to commence.
- Positive FDA feedback on rexlemestrocel-L for chronic pain.
- Progress in clinical trials and commercial manufacturing.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Plc Resources Limited (PLC) ORDINARY FULLY PAID |
Materials |
$9 |
Proposed issue of securities - PLC
|
29 Jan 2026 10:04AM |
$0.008 |
$0.008 |
fallen by
0%
|
|
| Plc Resources Limited (PLC) ORDINARY FULLY PAID |
Materials |
$9 |
Proposed issue of securities - PLC
|
29 Jan 2026 10:03AM |
$0.008 |
$0.008 |
fallen by
0%
|
|
| Plc Resources Limited (PLC) ORDINARY FULLY PAID |
Materials |
$9 |
Proposed issue of securities - PLC
|
29 Jan 2026 10:03AM |
$0.008 |
$0.008 |
fallen by
0%
|
|
| Plc Resources Limited (PLC) ORDINARY FULLY PAID |
Materials |
$9 |
Premier1 Completes 100% Acquisition of Yalgoo Gold Project
|
29 Jan 2026 10:03AM |
$0.008 |
$0.008 |
fallen by
0%
|
|
PLC - Price-sensitive ASX Announcement
Full Release
Key Points
- Premier1 completes 100% acquisition of Yalgoo Gold Project.
- Strategic location in Yalgoo-Singleton Greenstone Belt.
- Yalgoo Project covers 266 km² with proximity to major producers.
- Wadgingarra Gold Prospect Inferred Resource: 150,000 tonnes at 2.7g/t Au.
- Aims to maximize exploration and shareholder value.
- Simon Phillips appointed Executive Director to lead project.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Resource Minerals International Ltd (RMI) ORDINARY FULLY PAID |
Materials |
$121 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
29 Jan 2026 10:03AM |
$0.028 |
$0.130 |
risen by
364.29%
|
|
RMI - Price-sensitive ASX Announcement
Full Release
Key Points
- Operating cash outflows of $198k were reported.
- Investing activities included $426k spent on exploration and evaluation.
- A $1 million placement was completed to fund exploration and operational costs.
- RMI reported a cash balance of $557k at the end of the quarter.
- Available financing facilities amount to $5 million with RiverFort Global Capital.
- Exploration efforts focused on the Shaib Marqan project in Saudi Arabia and the Mpanda project in Tanzania.
- Payments to related parties totaled $101k for director fees and consultancy.
- RMI plans further drilling in its key projects.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Liontown Limited (LTR) ORDINARY FULLY PAID |
Materials |
$5,993 |
December 2025 Quarter Presentation
|
29 Jan 2026 10:02AM |
$2.080 |
$1.885 |
fallen by
9.38%
|
|
LTR - Price-sensitive ASX Announcement
Full Release
Key Points
- Transition to 100% underground operations completed.
- Strong financial performance with A$390M cash balance.
- 37% increase in ore production from underground operations.
- Completion of open pit mining at Kathleen Valley on schedule.
- Plant performance and safety measures improved.
- Targeted production increases to enhance operational efficiency.
- Emerging lithium deficits expected to support market prices.
- Continued growth strategy focusing on expansion and capital allocation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Comet Ridge Limited (COI) ORDINARY FULLY PAID |
Energy |
$118 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
29 Jan 2026 10:02AM |
$0.135 |
$0.099 |
fallen by
26.67%
|
|
COI - Price-sensitive ASX Announcement
Full Release
Key Points
- Comet Ridge Limited is focused on the development of the Mahalo Gas Hub projects.
- The Mahalo Gas Project has both Gas and Water FEED studies nearing completion.
- Comet Ridge executed an agreement with Jemena for the Mahalo Gas Hub Pipeline.
- The company has a secured loan facility with Pure Asset Management of $9.5 million.
- Net cash used in operating activities was $1.041 million for the current quarter.
- Cash and cash equivalents at the end of the period were $7.046 million.
- Comet Ridge plans to expand its gas sales from 28 TJ/d to between 70 and 75 TJ/d.
- Environmental approvals were received for the Mahalo North natural gas development.
- The company is exploring financing options for its share of the Mahalo Gas Project development capex.
- A retirement of a Non-Executive Director, Ms Gillian Swaby, occurred during the quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Elixinol Wellness Limited (EXL) ORDINARY FULLY PAID |
Consumer Staple |
$3 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 Jan 2026 10:02AM |
$0.011 |
$0.007 |
fallen by
40.91%
|
|
EXL - Price-sensitive ASX Announcement
Full Release
Key Points
- First underlying operating cash flow positive quarter achieved
- Q4 FY25 revenue of $4.1 million, up 9.5% quarter-on-quarter
- 42% revenue increase in Healthy Chef e-commerce sales year-on-year
- Operating costs reduced by 30% in Q4 FY25
- Reestablished position as dominant hemp supplier in Australia
- Company positioned for scalability and profitability with a focus on higher-margin sales
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Zimi Limited (ZMM) ORDINARY FULLY PAID |
Information Technology |
$3 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 Jan 2026 10:02AM |
$0.007 |
$0.003 |
fallen by
57.14%
|
|
ZMM - Price-sensitive ASX Announcement
Full Release
Key Points
- Invoiced revenue of $590,000 for the December 2025 quarter.
- Year-on-year revenue growth of 300% compared to December 2024.
- Customer receipts increased to $822,000.
- Progression of 'Senoa Matter' product range to industrialization.
- Advancements in digital sales and development of 'Ask Zimi' AI agent.
- CEO's strategic visit to China to strengthen partnerships.
- Appointment of Todd Milliner to enhance manufacturing expertise.
- Net cash from operating activities was $374,000.
- Total available funding was $958,000.
- Payments to related parties totaled $599,000.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Syntara Limited (SNT) ORDINARY FULLY PAID |
Health Care |
$44 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 Jan 2026 10:02AM |
$0.035 |
$0.023 |
fallen by
34.29%
|
|
SNT - Price-sensitive ASX Announcement
Full Release
Key Points
- Amsulostat clinical and preclinical data were presented at the ASH Annual Meeting.
- Initiation of the second myelodysplastic syndrome (MDS) study in Australia.
- Received positive European Medicines Agency opinion for Orphan Drug Designation.
- Announcement of a pancreatic cancer Phase 1/2 clinical trial funded by MRFF.
- SNT-4728 Phase 2 iRBD trial fully recruited with data expected in Q2 2026.
- Progression of SNT-9465 into hypertrophic scar study after Phase 1a study.
- Syntara's proforma cash balance at 31 December was $12.3 million.
- Net cash used in operating activities was $3.8 million for the quarter.
- No net cash used/generated from investing and financing activities.
- Cash and cash equivalents at the end of the period totaled $10.5 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| FBR Ltd (FBR) ORDINARY FULLY PAID |
Industrials |
$21 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 Jan 2026 10:01AM |
$0.003 |
$0.003 |
fallen by
0%
|
|
FBR - Price-sensitive ASX Announcement
Full Release
Key Points
- Factory Acceptance Test for Hadrian unit completed with a speed record.
- Memorandum of Understanding for Hadrian unit sale to Fraser Lyne Constructions.
- Successful demonstration of shipbuilding robot prototype for Samsung.
- First binding purchase order for Mantis welding robot received.
- Net cash used in operating activities: $2.1 million.
- Cash balance at quarter-end: $870,000.
- Share Subscription Facility of $20 million established.
- Exploration of additional financing options and government grant application.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| 6K Additive, Inc (6KA) CDI 1:1 US PERSON PROHIBITED EXCLUDING QIB |
Materials |
$129 |
Investor Webinar Update
|
29 Jan 2026 10:01AM |
$1.080 |
$0.740 |
fallen by
31.48%
|
|
| Aerometrex Limited (AMX) ORDINARY FULLY PAID |
Industrials |
$25 |
AMX delivers record first half revenue and EBITDA
|
29 Jan 2026 10:01AM |
$0.240 |
$0.265 |
risen by
10.42%
|
|
AMX - Price-sensitive ASX Announcement
Full Release
Key Points
- Aerometrex Limited delivered record first half revenue and EBITDA for the first half of the 2026 financial year.
- The company reported group statutory revenue between $12.75 million and $13.25 million, up 10% to 15% compared to the previous year.
- EBITDA increased significantly, expected between $3.25 million to $3.75 million, marking a 209% to 257% increase from the previous year.
- MetroMap, a key product, achieved a record Annual Contract Value (ACV) of approximately $12.29 million.
- LiDAR services showed a strong recovery with revenue between $6.2 million to $6.6 million.
- The company's cash balance stood at $3.67 million as of 31 December 2025, maintaining stable cash flow for three consecutive quarters.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Starpharma Holdings Limited (SPL) ORDINARY FULLY PAID |
Health Care |
$293 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 Jan 2026 10:01AM |
$0.350 |
$0.695 |
risen by
98.57%
|
|
SPL - Price-sensitive ASX Announcement
Full Release
Key Points
- Focus on executing strategic partnerships.
- Progress on internal radiopharmaceutical program.
- Highest online sales month for Viraleze™ achieved.
- Cash balance of $18.2 million.
- Payment of USD $5.5 million received from Genentech.
- Advancements in DEP® platform attracting industry attention.
- Participation in JP Morgan and Biotech Showcase conferences.
- Strategic priorities for 2026 include advancing radiotheranostic program.
- Certification as a Great Place to Work.
- Expansion of commercialization opportunities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| L1 Group Limited (L1G) ORDINARY FULLY PAID |
Financials |
$3,003 |
Timing of release of Half Year Financial Results
|
29 Jan 2026 10:00AM |
$1.165 |
$1.170 |
risen by
0.43%
|
|
| Benz Mining Corp (BNZ) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$885 |
Proposed issue of securities - BNZ
|
29 Jan 2026 10:00AM |
$2.740 |
$2.650 |
fallen by
3.28%
|
|
Call 1300 880 160
Start a chat
Schedule a call
